Beijing Time (UTC+8) | Local Time | Presentation Topic | Speaker | Affiliation / Organization |
---|---|---|---|---|
13:45-14:05 | 13:45-14:05 |
Novel biomarkers for the management of chronic hepatitis B |
Yasuhito Tanaka | Department of Orthopedic Surgery, Nara Medical University |
14:05-14:25 | 14:05-14:25 |
Definition of HBV cure and treatment endpoint |
George Lau | Humanity & Health Medical Group/The 5th Medical Centre of Chinese PLA General Hospital |
14:25-14:45 | 14:25-14:45 |
Basic biology of HBV: glance over cccDNA transcription |
Wenhui LI | National Institute of Biological Sciences, Beijing |
14:45-15:05 | 14:45-15:05 |
Quantitative anti-HBc but not HBcrAg can predict HBsAg clearance in sequential combination therapy with PEG-IFN-α in NAs-suppressed chronic hepatitis B patients |
Junliang FU | The Fifth Medical Center of Chinese PLA General Hospital |
15:05-15:15 | 15:05-15:15 |
Panel Discussion |